Search

A recent study conducted by researchers at Wannan Medical College in Anhui, China, has explored the anticancer activity of Brusatol (BT), a compound extracted from Brucea javanica, a traditional Chinese herbal medicine. The study found that BT has various biological and medical activities, including antitumor effects. It acts as a nuclear factor erythroid 2-related factor 2 (Nrf2) inhibitor and has shown potential in inhibiting cell proliferation, promoting tumor cell differentiation, inducing apoptosis, and suppressing angiogenesis. The research provides valuable insights into the molecular mechanisms of BT and its potential as an antitumor drug. [Extracted from the article]

A recent report from Huangshan University in Anhui, China discusses the formulation and characterization of silymarin liposomes for enhanced antitumor activity. Liposomes, which are nanoscale carriers, play a crucial role in drug delivery and affect the effectiveness of drugs in the body. The researchers optimized the liposomes using the response surface method and achieved high entrapment efficiency. In vitro studies showed that the silymarin liposomes had stronger inhibitory effects on cancer cells compared to the model drug. The researchers concluded that this liposome system is suitable for intravenous delivery to enhance the antitumor effects of silymarin. [Extracted from the article]

Researchers at Anhui Polytechnic University in China have conducted a study on the surface modification and functionalization of polyester fabrics using a deep eutectic solvent. The study found that treatment with the solvent resulted in increased fiber swelling and fineness, as well as improved stability and antibacterial properties. The researchers concluded that the solvent can physically etch and reproduce the fabric, allowing for the embedding of chitosan in the fibers. This research has been peer-reviewed and provides valuable insights into the potential applications of deep eutectic solvents in textile modification. [Extracted from the article]

A recent study conducted by investigators from Anhui Medical University in China focuses on the development of nanopharmaceuticals as a carrier-free nanodrug self-delivery system. The researchers aimed to address the limitations of small molecule targeted inhibitors, such as poor water solubility and low oral bioavailability. By self-assembling dasatinib and 5-fluorouracil, the researchers were able to create nanoparticles with different particle sizes. These nanoparticles exhibited aggregation-induced emission (AIE) effect, making them suitable for bioimaging and tracking cell trafficking. The study demonstrated that these nanodrugs showed enhanced antitumor efficacy and biocompatibility. [Extracted from the article]